SODIUM SULFACETAMIDE AND SULFUR
RxNorm 1005856· SULFACETAMIDE SODIUM, SULFUR· TOPICAL
BioComp Pharma, Inc.
Indications and usage
INDICATIONS: This product is indicated for use in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.
Dosage and administration
DOSAGE AND ADMINISTRATION: Cleanse affected areas. Apply a thin layer to the affected areas with light massaging, 1 to 3 times daily or as directed by a physician.
Warnings
WARNINGS: Sulfonamides are known to cause Stevens-Johnson syndrome in hypersensitive individuals. Stevens-Johnson syndrome also has been reported following the use of sodium sulfacetamide topically. Cases of drug-induced systemic lupus erythematosus from topical sulfacetamide also have been reported. In one of these cases, there was a fatal outcome. KEEP OUT OF THE REACH OF CHILDREN.
Contraindications
CONTRAINDICATIONS: This product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product. This product is not to be used by patients with kidney disease.
Adverse events
Most frequently reported events (FDA FAERS). Report frequency does not imply causation.
- pain9
- drug ineffective7
- nausea7
- anxiety5
- erythema5
- fall5
- hypersensitivity5
- rash5
- rosacea5
- dry skin4
- dyspnoea4
- eye irritation4
- malaise4
- product substitution issue4
- pulmonary embolism4
- urticaria4
Adverse reactions (label)
ADVERSE REACTIONS: Reports of irritation and hypersensitivity to sodium sulfacetamide are uncommon. The following adverse reactions, reported after administration of sterile ophthalmic sodium sulfacetamide, are noteworthy: instances of Stevens-Johnson syndrome and instances of local hypersensitivity which progressed to a syndrome resembling systemic lupus erythematosus; in one case a fatal outcome was reported (see WARNINGS).
KR · 한국Products in Korea (2)
- 설파클란로션10%(설파세타미드나트륨)(주)나노팜
- 클라론로오숀10%(설파세타미드나트륨)(주)나노팜
View more: Full FDA label on DailyMed →Label effective 20260112